Gonorrhoea strains across Europe becoming more susceptible to main treatment options
According to test results from the annual European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP), resistance levels to the main antimicrobials used for treatment of gonorrhoea infection have seen an encouraging decrease since 2010.
Dual-use research debates and public health: better integration would do no harm
This opinion article authored by ECDC staff, published in the Frontiers journal, gives a new light to the dual-use debate.
ECDC publishes interim case definition and case finding algorithm for reporting patients with A(H7N9)
The case definition and case finding algorithm have been prepared for surveillance purposes only and they will be adjusted as the current avian influenza A(H7N9) situation develops.
Emerging spread of new fungal species poses risk for healthcare settings in the EU/EEA
The rise in Europe of Candida auris infections, a difficult-to-control fungus, is of concern. The fungus spreads easily in healthcare settings, can cause invasive infections, and is also associated with resistance to multiple classes of anti-fungal medication.
Understanding drug-resistant gonorrhoea: an ECDC whole genome sequencing study
Can whole genome sequencing illustrate changes in drug susceptibility of gonorrhoea to antimicrobials used for treatment and so help to define more effective treatment regimens? The first study of this kind within an international surveillance programme for sexually transmitted infections shows distribution of drug-resistant gonorrhoea strains across Europe.
Link between public health microbiology and epidemiology necessary to tackle vaccine-preventable diseases in EuropeArchived
Today, the impact of vaccines on Public Health is at the centre of the discussions in the conference organised by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in Prague. This conference brought together experts to debate the many-sided correlations between vaccines, medicine and society at the dawn of the third millennium.
ECDC’s Director sets out vision for strengthening public health microbiologyArchived
At a special joint session combining experts from the National Microbiology Focal Points and ECDC's Advisory Forum, ECDC Director, Dr. Marc Sprenger, set out his vision for the agency’s role in strengthening public health microbiology across Europe: By 2016, ECDC will foster the development and facilitate the operation of an efficient public health microbiology system capable of providing timely and reliable information for infectious disease prevention and control at Member State and EU levels
ECDC training programme on public health microbiology (EUPHEM) starts new fellowship cohort and releases dedicated websiteArchived
A new cohort of fellows started the European Programme for Public Health Microbiology Training (EUPHEM) fellowships. ECDC is releasing a new website dedicated to EUPHEM.